Get informed when a big investor buys or sells
+ Follow$28.04
10 analysts in the last 4 months
High: $57 | Low: $24
No recommendations in the last 4 months.
Amylyx Pharmaceuticals posts a target price of $44. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
A target price of $44 for AMLX means covering analysts, on average, see the stock 58.0% upside of $28.04 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.
Context for AMLX's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Amylyx Pharmaceuticals's other metric pages and overview cover the third.